What's Happening?
Biotech startup Seadling has launched a new processing facility in Malaysia to enhance its production of seaweed-based functional ingredients. This expansion follows a $1 million seed funding round co-led by AgFunder and other investors. The facility will increase Seadling's production capacity from one ton to five tons per month. The company collaborates with farmers in Borneo to cultivate Elkhorn Seamoss, which undergoes a fermentation process to enhance its nutritional benefits. Currently, these seaweed products are used in pet food, with plans to expand into human consumption by 2027.
AD
Why It's Important?
Seadling's expansion is significant for the blue economy in Southeast Asia, a region where seaweed farming is a major industry. The company's efforts could lead to increased productivity and economic growth in the area. Seaweed is gaining attention as a sustainable ingredient that can benefit various industries, including food, pharmaceuticals, and cosmetics. By enhancing seaweed's nutritional profile, Seadling is positioning itself as a key player in the sustainable food market, potentially unlocking significant economic value in the region.
What's Next?
Seadling plans to continue focusing on the pet food industry while preparing to enter the human food market by 2027. The company is also working towards obtaining GMP+ certification for its products by the end of 2026. Geographic expansion is on the horizon, with plans to extend its market reach to India and Thailand, in addition to its current presence in Southeast Asia, the US, and the UK.
